176 related articles for article (PubMed ID: 33803218)
1. The Role of
Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
Cells; 2021 Mar; 10(3):. PubMed ID: 33803218
[TBL] [Abstract][Full Text] [Related]
2.
Vilkeviciute A; Cebatoriene D; Kriauciuniene L; Zemaitiene R; Liutkeviciene R
Mediators Inflamm; 2021; 2021():6622934. PubMed ID: 33953642
[TBL] [Abstract][Full Text] [Related]
3. Impact of
Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
Cancer Genomics Proteomics; 2021; 18(1):53-65. PubMed ID: 33419896
[TBL] [Abstract][Full Text] [Related]
4. Associations of IL6 rs1800795, BLK rs13277113, TIMP3 rs9621532, IL1RL1 rs1041973 and IL1RAP rs4624606 single gene polymorphisms with laryngeal squamous cell carcinoma.
Pasvenskaite A; Vilkeviciute A; Liutkeviciene R; Gedvilaite G; Liutkevicius V; Uloza V
Gene; 2020 Jul; 747():144700. PubMed ID: 32330537
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the association between ACYP2 and laryngeal squamous cell carcinoma risk in Chinese males.
Zhao W; Niu F; Xie Z; Yan M; Li J; Zhang Y; Chen J; Liu Q; Jin T
Mol Genet Genomic Med; 2019 Jul; 7(7):e00731. PubMed ID: 31140742
[TBL] [Abstract][Full Text] [Related]
6. Do
Mickevicius T; Vilkeviciute A; Glebauskiene B; Kriauciuniene L; Liutkeviciene R
In Vivo; 2020; 34(5):2499-2505. PubMed ID: 32871778
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma.
Zhou J; Yang Y; Zhang D; Zhou L; Tao L; Lu LM
PLoS One; 2017; 12(2):e0171116. PubMed ID: 28225775
[TBL] [Abstract][Full Text] [Related]
8. Association of SIRT1 single gene nucleotide polymorphisms and serum SIRT1 levels with laryngeal squamous cell carcinoma patient survival rate.
Vaiciulis P; Liutkeviciene R; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Uloza V
Cancer Biomark; 2022; 34(2):175-188. PubMed ID: 34719479
[TBL] [Abstract][Full Text] [Related]
9. Significance of MDM2-309 polymorphisms and induced corresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinoma.
Zhou J; Liu F; Zhang D; Chen B; Li Q; Zhou L; Lu LM; Tao L
DNA Cell Biol; 2014 Feb; 33(2):88-94. PubMed ID: 24325471
[TBL] [Abstract][Full Text] [Related]
10. Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma.
Tang D; Tang WJ; Shi XL; Li WP; Zhou H; Lu LM; Tao L
Acta Otolaryngol; 2016 Aug; 136(8):806-11. PubMed ID: 27400252
[TBL] [Abstract][Full Text] [Related]
11. DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.
Shen Z; Ren W; Bai Y; Chen Z; Li J; Li B; Jin T; Cao P; Shao Y
Oncotarget; 2016 Nov; 7(48):79596-79604. PubMed ID: 27793000
[TBL] [Abstract][Full Text] [Related]
12. The Role of ApoE Serum Levels and
Liutkeviciene R; Auzelyte J; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Vaiciulis P; Uloza V
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892323
[TBL] [Abstract][Full Text] [Related]
13. Association between laryngeal squamous cell carcinoma and polymorphisms in tumor necrosis factor related apoptosis induce ligand (TRAIL), TRAIL receptor and sTRAIL levels.
Verim A; Turan S; Farooqi AA; Kahraman OT; Tepe-Karaca C; Yildiz Y; Naiboglu B; Ozkan NE; Ergen A; Isitmangil GA; Yaylim I
Asian Pac J Cancer Prev; 2014; 15(24):10697-703. PubMed ID: 25605161
[TBL] [Abstract][Full Text] [Related]
14. The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms.
Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V
Discov Oncol; 2023 Jan; 14(1):8. PubMed ID: 36682035
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer.
Hao W; Zhu Y; Zhou H
Med Oncol; 2013 Mar; 30(1):333. PubMed ID: 23269580
[TBL] [Abstract][Full Text] [Related]
16. Associations of IL-18 and IL-9 expressions and gene polymorphisms with asthma.
Chen LX; Xu CM; Gao F; Zhu MF; Xu MJ; Zhang JR; Qian WX
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6931-6938. PubMed ID: 32633386
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms as non-modifiable susceptibility factors to laryngeal cancer.
Escalante P; Barría T; Cancino M; Rahal M; Cerpa L; Sandoval C; Molina-Mellico S; Suárez M; Martínez M; Cáceres DD; Quiñones LA; Varela NM
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338278
[TBL] [Abstract][Full Text] [Related]
18. [The association between genetic polymorphisms of GSTM1, GSTT1, GSTP1 and susceptibility to laryngeal carcinoma from the Han people in Guangdong zone].
Tian S; Zhang J; Xiao Q; Zhai J; Yan X; Huang M; Chen F; Li Q; Guan Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 25(5):204-10. PubMed ID: 21604464
[TBL] [Abstract][Full Text] [Related]
19. Determination of
Uloza V; Tamauskaite T; Vilkeviciute A; Pasvenskaite A; Liutkevicius V; Liutkeviciene R
Dis Markers; 2019; 2019():3907232. PubMed ID: 31781300
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.
Ekizoglu S; Seven D; Ulutin T; Guliyev J; Buyru N
BMC Cancer; 2018 Apr; 18(1):477. PubMed ID: 29703252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
